Glytec Clinches Gold Stevie Award for Healthcare Excellence in 2025
In a significant recognition of its impact on healthcare, Glytec has been awarded the Gold Stevie Award as the Healthcare Technology Company of the Year. This accolade was presented during the second annual Stevie Awards for Technology Excellence, highlighting the company's commitment to revolutionizing diabetes management through innovative technology. Glytec's platform is at the forefront of addressing a major health challenge in hospitals: diabetes management.
With the increasing prevalence of diabetes within inpatient settings, Glytec has positioned itself as a leader in providing AI-driven solutions that optimize insulin management and improve patient outcomes. The flagship product, Glucommander®, stands out as the first FDA-cleared cloud-based software for personalized insulin dosing in hospitals. This groundbreaking technology helps healthcare providers make informed decisions regarding insulin administration, leading to better management of patients with diabetes and related conditions.
The recognition from the Stevie Awards comes at a crucial point for healthcare institutions in the U.S. As they brace for new glycemic management measures mandated by the Centers for Medicare & Medicaid Services (CMS), Glytec's solutions, already implemented in over 400 hospitals, become even more vital. By employing Glucommander®, hospitals can seamlessly meet the upcoming standards, thereby improving the quality of care for diabetic patients and enhancing clinical workflows.
The nomination process for the Stevie Awards saw a vast representation from organizations worldwide, with over 1,500 nominations submitted from 36 countries. The competition was fierce, demonstrating the incredible advancements being made across various sectors of technology. Glytec's win in the Healthcare Technology Solution category underscores the significant progress the company has made over its nearly two decades of operation. The judges' panel comprised over 160 professionals from diverse sectors, further validating the merit of Glytec's achievement.
Patrick Cua, the CEO of Glytec, expressed his gratitude for the recognition, emphasizing the company’s extensive experience in diabetes management. "This award not only acknowledges our technology's effectiveness but also reflects the vast data and insights we've accumulated—over 50 billion data points which power our analytics and AI-driven solutions. We are proud of the impact we are making in transforming diabetes care in hospitals and beyond," he stated.
Alongside the technology itself, Glytec's platform is supported by significant intellectual property, with over 100 patents, and more than 100 clinical publications backing its efficacy and innovation. This robust foundation helps to instill confidence in the healthcare providers that use its solutions.
The awards ceremony is scheduled for September 16 at the Marriott Marquis Hotel in New York City, providing a platform for Glytec and other honorees to celebrate their remarkable achievements and contributions to the technology landscape. This event promises to be a showcase of innovation and an opportunity to network with other leaders in technology.
Glytec's recognition at the Stevie Awards highlights the importance of technology in healthcare and sets a benchmark for excellence within the industry. By empowering healthcare professionals with cutting-edge tools for diabetes management, Glytec is not just setting a standard for technological advancement but also leading a movement to enhance patient care across the board. For more details on Glytec's offerings, visit www.glytec.com or check out their profile on LinkedIn.
With the increasing prevalence of diabetes within inpatient settings, Glytec has positioned itself as a leader in providing AI-driven solutions that optimize insulin management and improve patient outcomes. The flagship product, Glucommander®, stands out as the first FDA-cleared cloud-based software for personalized insulin dosing in hospitals. This groundbreaking technology helps healthcare providers make informed decisions regarding insulin administration, leading to better management of patients with diabetes and related conditions.
The recognition from the Stevie Awards comes at a crucial point for healthcare institutions in the U.S. As they brace for new glycemic management measures mandated by the Centers for Medicare & Medicaid Services (CMS), Glytec's solutions, already implemented in over 400 hospitals, become even more vital. By employing Glucommander®, hospitals can seamlessly meet the upcoming standards, thereby improving the quality of care for diabetic patients and enhancing clinical workflows.
The nomination process for the Stevie Awards saw a vast representation from organizations worldwide, with over 1,500 nominations submitted from 36 countries. The competition was fierce, demonstrating the incredible advancements being made across various sectors of technology. Glytec's win in the Healthcare Technology Solution category underscores the significant progress the company has made over its nearly two decades of operation. The judges' panel comprised over 160 professionals from diverse sectors, further validating the merit of Glytec's achievement.
Patrick Cua, the CEO of Glytec, expressed his gratitude for the recognition, emphasizing the company’s extensive experience in diabetes management. "This award not only acknowledges our technology's effectiveness but also reflects the vast data and insights we've accumulated—over 50 billion data points which power our analytics and AI-driven solutions. We are proud of the impact we are making in transforming diabetes care in hospitals and beyond," he stated.
Alongside the technology itself, Glytec's platform is supported by significant intellectual property, with over 100 patents, and more than 100 clinical publications backing its efficacy and innovation. This robust foundation helps to instill confidence in the healthcare providers that use its solutions.
The awards ceremony is scheduled for September 16 at the Marriott Marquis Hotel in New York City, providing a platform for Glytec and other honorees to celebrate their remarkable achievements and contributions to the technology landscape. This event promises to be a showcase of innovation and an opportunity to network with other leaders in technology.
Glytec's recognition at the Stevie Awards highlights the importance of technology in healthcare and sets a benchmark for excellence within the industry. By empowering healthcare professionals with cutting-edge tools for diabetes management, Glytec is not just setting a standard for technological advancement but also leading a movement to enhance patient care across the board. For more details on Glytec's offerings, visit www.glytec.com or check out their profile on LinkedIn.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.